We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
QuickQueue enables users to order-ahead for food & drinks in quick-service restaurants - with orders paid-for, ready to collect upon arrival and loyalty points automatically saved on their phone. With QuickQueue, users save time and money, while retailers increase profits by intensifying customer loyalty and gaining unparalleled customer analytics.
days to go: Expired investment: £283,124
Established by a team from a Michelin star restaurant, The Gaff is a small plate restaurant offering food in contemporary, comfortable, and relaxed surroundings. The first restaurant was opened in May 2019 and aspires for a Michelin Accreditation. The concept of small plate menus was the fourth biggest restaurant concept trend of 2019 which Gaff wants to capture. Gaff has been reviewed in The Good Food Guide 2020 and mentions by prominent food bloggers such as Kavita Favelle. They have also received good customer ratings with over 87% 5-star rating on Res Diary and a 75% rating on TripAdvisor. The funds raised will be utilised to open a second restaurant in Bath and three more around the UK.

Pitch Rated

31%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £71,950
Big Night is an online food delivery service that partners with selected independent food vendors to deliver exceptional meals to customers at home, in their office or wherever they choose. The company asserts that 61% of non-millennials find delivery overall frustrating. Big Night aims to change this scenario. It has signed on ten notable restaurants and has ten more in the immediate pipeline. Onboarded restaurants include Two Lights, Luca, The Laughing Heart, Sager + Wilde, Royale, Levan, AngloThai, Legare and Mangal2. Over 4,000 people have ordered via Big Night since its launch. The company will use 25% of the investment for operations, 25% for marketing, and 50% to improve the Big Night platform.

Pitch Rated

60%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £274,168
Sugar Crave is an award-winning treat delivery service that has sold more than 13 tonnes of Pick N Mix in their first year. The company have won the Best Online Business 2019 award with Shropshire Chamber of Commerce and has also seen growth of 4000% in Year 1 to £67,959 with a profit of £27,291. Additionally, from covering 5,000 postcodes, the company now caters to 79,500 postcodes in Yr 1, with the aim to deliver within 60 minutes from order, Sugar Crave is working towards increasing its coverage across the UK by 2022. With the proceeds, the company will increase the range and expand coverage to all 52 major UK towns & cities.

Pitch Rated

41%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £131,940
WELD is a fitness company on a mission to make on-demand health, fitness and wellbeing available to all ages & abilities. The company allows users and instructors to set the time and place for the training session, rent out their home or commercial spaces for activities, or interact 1-2-1 online. This approach, the company believes, helps personal trainers, hit by the Covid-19 lockdown, find clients. WELD also allows trainers to set their prices and keep 90% of their fees, and lets customers enjoy a 2% commission on referrals for every future session taken in perpetuity. WELD aims to tap into the $94 billion global fitness and wellness market that grew 8.7% from 2018/19. The company's primary target audience is Generation Z that, the company believes, embraced wellness. WELD will use the investment to improve its platform, boost marketing and plug the fitness & wellness gap. 

Pitch Rated

56%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £199,227
Plant-based diets, health and fitness programmes for those interested in veganism to improve their health and wellbeing. Skinny Bitch's book has sold more than 1.1m copies and is available in 6 languages. Readers of the book include celebrities such as Eva Longoria and Jessica Alba. Ellen DeGeneres has stated that the Skinny Bitch book is the reason she became vegan. The company is now expanding their brand further by offering their content through online guides and blogs. Skinny Bitch is also intending to generate revenue via vegan supplements produced in the US to be sold through their website and third party e-commerce channels.
days to go: Expired investment: £75,810
Sauce of Nature are a fresh pesto brand free from additives and preservatives, being marketed as more than just a stir through pasta sauce but also to be drizzled over salad, as an accompaniment to meat, fish and vegetables or simply enjoyed on its own. They aim to be recognised nationally and internationally and are working on further products such as a vegan range. 
days to go: Expired investment: £36,140
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph